Active-ingredient Dossier
Ticagrelor
Active-ingredient Dossier for Ticagrelor (platelet aggregation inhibitor). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: ARX-Ticagrelor
- Brand: BRILINTA
- Brand: BRICALOR
- Brand: MSN-TICAGRELOR
- Brand: TICALOR
- Brand: APO-TICAGRELOR
- Therapeutic area: Cardiology
What is
Ticagrelor Ticagrelor is a platelet aggregation inhibitor.
Australian brands containing
Ticagrelor — ARX-Ticagrelor — BRILINTA — BRICALOR — MSN-TICAGRELOR — TICALOR
Therapeutic areas
Ticagrelor is registered in immunology (14 brands) and cardiology (1 brand).
Sponsor landscape
Ticagrelor is marketed by nine sponsors including Medreich, AstraZeneca, Accelagen, Nova Pharmaceuticals, Arrotex Pharmaceuticals, and Pharmacor.
PBS and regulatory activity
One brand containing ticagrelor has PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome is 1 March 2023.